SPONSOR
Azienda USL Reggio Emilia - IRCCS
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: Idiopathic Parkinson's Disease (PD)Primary Ovarian LeiomyosarcomaClassical Hodgkin LymphomaClassical Hodgkin Lymphoma RecurrentClassical Hodgkin Lymphoma Refractory
Azienda USL Reggio Emilia - IRCCS is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Idiopathic Parkinson's Disease (PD), Primary Ovarian Leiomyosarcoma, Classical Hodgkin Lymphoma, Classical Hodgkin Lymphoma Recurrent.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Azienda USL Reggio Emilia - IRCCS
How many clinical trials has Azienda USL Reggio Emilia - IRCCS sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Azienda USL Reggio Emilia - IRCCS, of which 3 are actively recruiting participants. These trials cover conditions including Idiopathic Parkinson's Disease (PD), Primary Ovarian Leiomyosarcoma, Classical Hodgkin Lymphoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Azienda USL Reggio Emilia - IRCCS research focus on?
Azienda USL Reggio Emilia - IRCCS clinical trials span Idiopathic Parkinson's Disease (PD), Primary Ovarian Leiomyosarcoma, Classical Hodgkin Lymphoma, Classical Hodgkin Lymphoma Recurrent, Classical Hodgkin Lymphoma Refractory. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Azienda USL Reggio Emilia - IRCCS clinical trial?
To participate in a Azienda USL Reggio Emilia - IRCCS trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Azienda USL Reggio Emilia - IRCCS trials with current recruitment status updated daily.
Clinical Trials by Azienda USL Reggio Emilia - IRCCS
NCT06814431
Recruiting
Study on the Incidence of Malignant Neoplasms in Patients With Parkinson's Disease and Heterozygous Mutation of the GBA Gene
Idiopathic Parkinson's Disease (PD)
NCT06749600
Recruiting
Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma
Primary Ovarian Leiomyosarcoma
NCT06822855
Recruiting
Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
Classical Hodgkin Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology